Literature DB >> 35145308

Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project.

Arun J Sanyal1, Sudha S Shankar2, Roberto A Calle3, Anthony E Samir4, Claude B Sirlin5, Sarah P Sherlock6, Rohit Loomba7, Kathryn J Fowler5, Clayton A Dehn8, Helen Heymann9, Tania N Kamphaus9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35145308      PMCID： PMC9588405          DOI： 10.1038/s41591-021-01652-8

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  6 in total

1.  The FNIH Biomarkers Consortium embraces the BEST.

Authors:  Joseph P Menetski; Christopher P Austin; Linda S Brady; Guy Eakin; Chris Leptak; Abbey Meltzer; John A Wagner
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

Review 2.  Non-alcoholic fatty liver disease - A global public health perspective.

Authors:  Zobair M Younossi
Journal:  J Hepatol       Date:  2018-11-09       Impact factor: 25.083

Review 3.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

Review 4.  Current status of imaging in nonalcoholic fatty liver disease.

Authors:  Qian Li; Manish Dhyani; Joseph R Grajo; Claude Sirlin; Anthony E Samir
Journal:  World J Hepatol       Date:  2018-08-27

Review 5.  Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Arinc Ozturk; Chetan K Potu; Ashley L Louie; Vivian Montes; Walter C Henderson; Kang Wang; Michael P Andre; Anthony E Samir; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2019-03-12       Impact factor: 4.813

6.  Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Laura A Wilson; Cynthia Behling; Cynthia Guy; Melissa Contos; Oscar Cummings; Matthew Yeh; Ryan Gill; Naga Chalasani; Brent A Neuschwander-Tetri; Anna Mae Diehl; Srinivasan Dasarathy; Norah Terrault; Kris Kowdley; Rohit Loomba; Patricia Belt; James Tonascia; Joel E Lavine; Arun J Sanyal
Journal:  JAMA Netw Open       Date:  2019-10-02
  6 in total
  3 in total

1.  What's new in non-alcoholic fatty liver disease?

Authors:  Jessica Spiers; James Hallimond Brindley; Wenhao Li; William Alazawi
Journal:  Frontline Gastroenterol       Date:  2022-05-31

2.  Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study.

Authors:  Liping Wang; Jinzhong Dong; Miao Xu; Li Li; Naibin Yang; Guoqing Qian
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria.

Authors:  Jae Seung Lee; Hye Won Lee; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Jae Young Jang; Soo Young Park; Hyun Woong Lee; Chun Kyon Lee; Seung Up Kim
Journal:  Front Med (Lausanne)       Date:  2022-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.